Open AccessIncidence of metastasis and prostate-specific antigen levels at diagnosis in Gleason 3+4 versus 4+3 prostate cancer
Author(s) -
Mohamed H. Kamel,
Mahmoud Khalil,
Wilson Alobuia,
Joseph Su,
Rodney Davis
Publication year - 2018
Publication title -
urology annals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.355
H-Index - 20
eISSN - 0974-7834
pISSN - 0974-7796
DOI - 10.4103/ua.ua_124_17
Subject(s) - medicine , prostate cancer , prostate specific antigen , incidence (geometry) , clinical endpoint , oncology , prostate , population , log rank test , cancer , proportional hazards model , clinical trial , optics , physics , environmental health
The aim is to assess for a difference in the incidence of metastasis (IM) and prostate-specific antigen (PSA) levels at diagnosis in patients with Gleason score (GS) 3+4 versus 4+3 prostate cancer using a large veterans affairs database.